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Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the selective loss of upper
and lower motor neurons, a cell type that is intrinsically more vulnerable than other cell types to exogenous stress.
The interplay between genetic susceptibility and environmental exposures to toxins has long been thought to be
relevant to ALS. One cellular mechanism to overcome stress is the formation of small dense cytoplasmic domains
called stress granules (SG) which contain translationally arrested mRNAs. TDP-43 (encoded by TARDBP) is an
ALS-causative gene that we have previously implicated in the regulation of the core stress granule proteins G3BP
and TIA-1. TIA-1 and G3BP localize to SG under nearly all stress conditions and are considered essential to SG
formation. Here, we report that TDP-43 is required for proper SG dynamics, especially SG assembly as marked by
the secondary aggregation of TIA-1. We also show that SG assembly, but not initiation, requires G3BP. Furthermore,
G3BP can rescue defective SG assembly in cells depleted of endogenous TDP-43. We also demonstrate that
endogenous TDP-43 and FUS do not have overlapping functions in this cellular process as SG initiation and
assembly occur normally in the absence of FUS. Lastly, we observe that SG assembly is a contributing factor in the
survival of neuronal-like cells responding to acute oxidative stress. These data raise the possibility that disruptions of
normal stress granule dynamics by loss of nuclear TDP-43 function may contribute to neuronal vulnerability in ALS.
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Background
Amyotrophic Lateral Sclerosis (ALS) is a late-onset neu-
rodegenerative disease characterized by the selective loss
of upper and lower motor neurons. It is inevitably fatal
with patients experiencing a progressive and rapid par-
alysis owing to a relentless denervation of nearly all
muscles. ALS can be either inherited with 10% of cases
having a familial history, or be sporadic where etiology
remains unknown but exposure to environmental stres-
ses are strongly suspected to be relevant [1]. Of the fa-
milial cases, ~4% are due to mutations in TARDBP,
encoding TAR DNA Binding Protein (TDP-43) [2,3].
Interestingly, a proportion of sporadic ALS cases have also
been attributed to TDP-43 mutations [2,3]. TDP-43 is a
heterogeneous nuclear ribonucleoprotein (hnRNP) and is
reported to function in multiple aspects of RNA metabol-
ism including transcription, splicing, and stabilization [4].
Mutations in a second hnRNP, FUS/TLS (Fused in sar-
coma/translocated in sarcoma), are also causative for ALS
[5,6]. TDP-43 and FUS are expected to function similarly
in RNA metabolism [4].
Mammalian cells possess a variety of mechanisms to
mediate cellular recovery following stress exposure. One
process is the transient formation of stress granules
(SG), small cytoplasmic inclusions (≤ 5 μm) that rapidly
form following exposure to chemical, viral or thermal
stress [7,8]. SG contain several RNA-binding proteins,
stalled pre-initiation complexes and translationally
arrested mRNAs. They are believed to function as sites
for mRNA storage and sorting, permitting a rapid re-
integration of these stalled pre-initiation complexes once
the stress has been cleared [8]. SG formation is a highly
regulated process that is initiated by the self-
oligomerization of the core SG proteins G3BP (RasGAP
SH3 domain binding protein 1) and TIA-1 (T-cell intra-
cellular antigen) within 15-20 min of stress exposure
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[9,10]. In the case of acute oxidative stress, several small
SG fuse into fewer but larger SG over the next 60 min.
This secondary aggregation is referred to as SG assembly
[8]. By 2 hours post-stress exposure, SG disassemble and
cellular processes return to normal [11,12]. Thus, SG are
a transient mechanism to halt general protein translation
and give translational priority to specific transcripts that
are necessary for the cell to overcome the encountered
stress [11].
Efficient SG kinetics are considered imperative to cell
survival following exposure to a variety of physiological
and environmental stresses [13-15]. Impaired SG signal-
ling as a contributing factor in neurodegenerative dis-
eases has been previously documented. Specifically,
depletion or mutation of FMRP, the gene responsible for
the neurological Fragile X syndrome, induces a severe
impairment in SG dynamics [16]. A variant in SMN re-
sponsible for the motor neuron disease spinal muscular
atrophy (SMA) fails to be recruited normally to SG in
SMA patient cells [17]. Ataxin-2, mutated in spinocere-
bellar ataxia type 2 and recently linked as a susceptibility
gene for ALS, localizes to and regulates SG formation
[18-22].
TDP-43 and FUS both localize to SG in response to
oxidative, thermal, osmotic, and proteasomal stress
[12,23-28]. TDP-43 is localized to cytoplasmic inclusions
in post-mortem tissue from ALS patients and since some
of these inclusions are also positive for SG markers,
some have suggested that deregulation of SG may drive
inclusion formation [23,29,30]. However, in a cell-based
assay, very few TDP-43 positive SG actually proceed to
aggregate formation [30]. Thus, it is important to re-
member that the other striking pathological feature
observed in patient motor neurons is the depletion of
the nuclear pool of TDP-43. Whether TDP-43 mutations
are a gain or loss of function (or both) is currently a
matter of debate [4,31,32]. However, it has recently been
proposed that TDP-43 pathogenesis might arise from a
loss of nuclear TDP-43 function (and/or gain of cyto-
plasmic function) [31]. In fact, data from yeast to
rodents indicates that TDP-43 mediated toxicity corre-
lates better with a loss of normal TDP-43 function than
with the presence/generation of TDP-43 cytoplasmic
aggregates [31,33]. TDP-43 is primarily localized to the
nucleus. Thus, in order to mimic the nuclear depletion
that is universally observed in neurons of patient brains
and spinal cords [34,35], we have employed siRNA-
specific depletion of TDP-43 as a model of loss of nu-
clear function. Using this system, we have previously
demonstrated that TDP-43 modulates the expression of
the core SG factors G3BP and TIA-1 [12]. Here, we have
addressed the role of endogenous TDP-43 in SG forma-
tion and assembly in response to oxidative stress docu-
menting that endogenous TDP-43 and FUS do not have
overlapping functions in this process. Furthermore, we
report that the TDP-43 target gene G3BP is required for
SG assembly but not initiation. Surprisingly, we demon-
strate that blocked SG assembly (secondary TIA-1
aggregation) has a differential effect on the survival of
neuronal and non-neuronal cells responding to acute
oxidative stress exposure.
Results
Endogenous TDP-43 regulates SG assembly as marked by
secondary TIA-1 aggregation
We have previously demonstrated that TDP-43 deple-
tion leads to a defect in the timing of SG formation in
response to acute oxidative stress induced by sodium
arsenite (SA) treatment [12]. In addition, we reported
that SG in TDP-43 depleted cells assayed immediately
after the stress were 43% smaller than control cells [12],
but the number of SG per cell is comparable to siCon-
trol cells (73.4 ± 3.6 vs. 82.2 ± 6.4, p = 0.15). These data
suggest a potential role for TDP-43 in SG dynamics. It is
well documented that following initial SG formation, SG
slowly reduce in number but each individual SG
increases in size before resolving. This SG size increase
is attributed to the fusion of multiple TIA-1 oligomers
and is referred to as SG assembly [8]. However, the
mechanism(s) which mediate this step is unclear.
Building on our previous published data in which we
validated two independent TDP-43 specific siRNAs, we
selected one of these siRNAs for transfection into HeLa
cells and then subsequently stressed the cells for 30 min
with 0.5 mM SA followed by recovery with fresh media.
Cells were subsequently fixed at 60 and 90 min and SG
were visualized with TIA-1 labelling (Figure 1A). In
HeLa cells transfected with control siRNA (siControl),
we observed an average of 84 ± 5 SG per cell with an
average size of 1.9 ± 0.1 μm2 at 60 min, followed by a re-
duction in SG number (60 ± 6 SG, p = 0.005) and an in-
crease in SG size (to 3.0 ± 0.1 μm2, p = 0.009) at 90 min
(Figure 1B). This simultaneous decrease in SG number
and increased SG size is due to the secondary aggrega-
tion of TIA-1 oligomers and is referred to as SG assem-
bly [8]. In cells depleted of endogenous TDP-43, SG
assembly is blocked such that SG number and size
remains unchanged at both time points examined
(Figure 1B). A second TDP-43 targeted siRNA also
yielded the same results (Additional file 1: Figure S1).
Moreover, this blockade in SG assembly was also true in
SK-N-SH cells, a neuronal-like cell line (Figure 1C).
To further evaluate whether TIA-1 oligomerization
was disrupted in SG assembly, we performed a protease
sensitivity assay. Briefly, SG assembly is reflected as
increased TIA-1 aggregation and thus increased protease
resistance [9,36]. Cells transfected with TDP-43 or con-
trol siRNA were stressed with SA and then permitted to
Aulas et al. Molecular Neurodegeneration 2012, 7:54 Page 2 of 14
http://www.molecularneurodegeneration.com/content/7/1/54
recover for 60 min before cytoplasmic fractions were
subject to a titration of Proteinase K (PK) and blotted
for TIA-1. In siControl cells, we observed an increased
resistance of TIA-1 to proteolysis between stressed and
unstressed cells (Figure 1D, compare lanes 5 and 11;
Figure 1E). In contrast, TIA-1 protease-sensitivity in SA-
treated TDP-43 depleted cells was comparable to un-
treated cells, indicating decreased TIA-1 aggregation
and thus impaired SG assembly (Figure 1D, compare
lanes 11 and 23, red arrows; Figure 1E). Collectively,
these experiments demonstrate that endogenous TDP-
43 is required for normal SG assembly.
The TDP-43 target G3BP is required for SG assembly but
not initiation
We have previously reported that G3BP is down-regulated
in cells depleted of TDP-43 via two independent siRNAs
[12]. We hypothesized that the SG assembly defect
observed in TDP-43 depleted cells could be attributed to
decreased G3BP expression. To address this, we reduced
G3BP levels using a gene-specific siRNA to levels compar-
able to cells treated with TDP-43 siRNA (remaining G3BP
protein in siG3BP vs. siTDP-43 in HeLa cells: p = 0.08; in
SK-N-SH: p = 0.32; Figure 2A, B). Importantly, we noted
that G3BP depletion does not impact TDP-43 expression
Figure 1 TIA-1 secondary aggregation is impaired by TDP-43 depletion. (A-D) Cells where transfected with control or TDP-43 siRNA for
72 hr and subsequently treated with SA. (A) Representative images of SG in HeLa cells at 60 and 90 min. Scale bar, 10 μm. (B & C) Quantification
of SG number and size by semi-automatic analysis using ImageJ at 60 and 90 min after SA treatment in (B) HeLa and (C) SK-N-SH cells. The
means of 3 independent experiments ± SEM are plotted. * p<0.05. (D) siRNA transfected HeLa cells were treated with or without SA and
collected 1 hr post-SA. Cytoplasmic extracts were digested with 0, 0.1, 0.2, 0.4, 0.8 or 1.6 mg/ml Proteinase K and assayed by immunoblot. TIA-1 is
more protease-sensitive when TDP-43 is absent (arrows). Data is representative of 3 independent experiments. (E) Quantification of remaining
TIA-1 protein following treatment with 0. 8 mg/ml Proteinase K, expressed relative to untreated samples.
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(HeLa: p = 0.071, SK-N-SH: p = 0.21; Figure 2A, B).
G3BP is considered essential for SG initiation based
on studies where overexpression of G3BP is sufficient
to nucleate SG [10]. However, unlike TIA-1, which is
required for SG initiation, the impact of G3BP on SG
initiation by either siRNA or genetic deletion has not
been reported. To define if G3BP is necessary for SG
initiation at endogenous expression levels, we counted
the number of SG per cell and measured SG size in
G3BP-depleted conditions immediately following a 30
min SA exposure. We observed that the number of
SG per cell was equivalent in siControl and siG3BP
cells (113 ± 3 vs. 117 ± 11 SG per cell, p = 0.373,
Additional file 2: Figure S2). Moreover, we did not detect
a difference in initial SG size (1.7 ± 0.1 vs. 1.8 ± 0.1 μm2,
p = 0.398, Additional file 2: Figure S2). Since SG compos-
ition can vary between cell types, we also evaluated SK-N-
SH cells and observed strikingly similar results with
respect to SG number (55 ± 8 vs. 63 ± 13 SG per cell, p =
0.332) and size (1.43 ± 0.01 vs. 1.42 ± 0.03 μm2, p =
0.366). Together, these data indicate G3BP is a non-
essential factor in the initiation of SG in response to acute
oxidative stress induced by SA.
To evaluate the role of G3BP in SG assembly, we quan-
tified the number of SG per cell as well as individual SG
size at 60 and 90 min after SA treatment. Visual inspec-
tion of SG by confocal suggested a difference in SG num-
ber and size in siG3BP cells compared to controls.
Quantification of individual SG in these cells revealed
that the number and the size of SG in siG3BP HeLa cells
is comparable to siControl cells at 60 min (p = 0.243 and
p = 0.400, respectively; Figure 2C). In contrast, while aver-
age SG size increases 1.6-fold in siControl cells (p = 0.004)
as expected, siG3BP cells remain constant at 1.9 ± 0.1
μm2. We obtained similar results with a second siRNA for
G3BP (Additional file 1: Figure S1) and in SK-N-SH cells
(Figure 2D) indicating that the requirement of G3BP for
SG assembly is not a cell-type specific event. Taken to-
gether, our data demonstrate G3BP as an important factor
in SG assembly, but not SG initiation as previously
suggested.
G3BP rescues the defect in SG assembly observed in
TDP-43 depleted cells
Our previous work indicated that TDP-43 depletion
using two independent siRNAs resulted in a robust and
Figure 2 The TDP-43 target gene G3BP is required for SG assembly. (A) Western blot to confirm efficacy of indicated siRNAs in HeLa (left
panel) and in SK-N-SH (right panel) cells. Actin serves as a loading control. (B) Quantification of protein levels demonstrating that G3BP does not
regulate TDP-43 in HeLa (left panel) nor in SK-N-SH (right panel). (C & D) Quantification of individual SG size and number in siRNA treated cells,
at 60 and 90 min after SA treatment in (C) HeLa cells and (D) SK-N-SH cells. The means of 3 independent experiments ± SEM are plotted. *
p < 0.05. siControl in Figure 2C is the same presented in Figure 4A,B. siControl in Figure 2D is the same presented in Figure 1C.
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reproducible decrease in G3BP expression [12]. To in-
vestigate whether the defect in SG assembly observed in
TDP-43 depleted cells could be attributed to G3BP, we
transiently expressed GFP-tagged G3BP in TDP-43
depleted cells, at a level comparable to endogenous
G3BP expression (Figure 3A). Using our conditions,
where we transfected 0.3 μg of G3BP-GFP cDNA for 24
hr, we detected cells of both high and low expression by
immunofluorescence. Consistent with a previous report,
G3BP overexpression at high levels induces the spontan-
eous formation of SG [10] (Figure 3B, asterisks) such
that 60 ± 0.4% of transfected cells formed SG in the
absence of SA treatment (Figure 3C). Interestingly, we
noted that the depletion of TDP-43 resulted in a 1.9-fold
reduction in the number of cells with spontaneous SG
formation suggesting that endogenous TDP-43 partici-
pates in this process (p = 0.0006).
In order to address our initial hypothesis that G3BP
mediates SG assembly in TDP-43 depleted cells, we
selected transfectants with low G3BP-GFP expression
for further analysis. Low expression was defined via
measurement of the GFP signal in individual cells. Cells
having an average pixel intensity below 60 arbitrary
fluorescent units were uniquely included in the subse-
quent quantification. This population of low-expressing
G3BP-GFP cells do not exhibit spontaneous SG forma-
tion (Figure 3B, arrowheads). As expected, cells co-
transfected with control siRNA and control GFP cDNA
undergo normal SG assembly while siTDP-43 cells
transfected with GFP cDNA demonstrate a defect in SG
assembly (Figure 3D-F). The low expression of G3BP-
GFP in TDP-43 depleted cells restored the number and
size of SG at 90 min to levels equivalent to controls, in-
dicating a restoration of SG assembly (Figure 3E, F).
Thus, the defect in SG assembly in TDP-43 depleted
cells can be rescued by G3BP expression. These data in-
dicate that G3BP functions downstream of TDP-43 in
SG assembly.
SG formation and assembly does not require
endogenous FUS
There have been several reports that a second ALS-
causing gene FUS/TLS, which is an hnRNP like TDP-43,
localizes to SG in response to oxidative stress [26-28].
All of these studies demonstrated SG localization of
over-expressed FUS protein, but do not evaluate the
contribution of endogenous FUS to this process. Since
there is suggestion that TDP-43 and FUS participate in
similar biological processes [37-40], we investigated the
potential role of endogenous FUS in SG dynamics in re-
sponse to oxidative stress using siRNA depletion in
HeLa cells. We did not observe any difference in the
number of cells able to form TIA-1 labelled SG in re-
sponse to SA treatment at any time point examined
(data not shown). Furthermore, SG initiation (number
and size at 30 min) was undisturbed in cells depleted of
FUS (Additional file 2: Figure S2). Similarly, SG assem-
bly proceeded normally as SG number and size were
similar between siControl and siFUS cells at 60 and 90
min post-stress (Figure 4A, B). These data were con-
firmed with a second siRNA specific for FUS (Additional
file 1: Figure S1). Since TDP-43 depletion can alter the
expression of TIA-1 and G3BP [12], we also evaluated
the levels of these proteins in siFUS cells. FUS depletion
(92% in HeLa and 68% in SK-N-SH) did not impact
TIA-1 or G3BP protein expression in HeLa or SK-N-SH
cells (Figure 4C, D). We also noted that FUS depletion
does not impact the expression of endogenous TDP-43
(Figure 4C, D) nor does it impact TDP-43 localization to
SG (data not shown). We conclude that endogenous
wild type FUS does not participate in SG initiation or
assembly in response to acute oxidative stress.
TDP-43 mediates cellular vulnerability to oxidative stress
in neuronal-like cells
SG comprise one arm of an integrated cellular stress
response. Previous data indicate that a failure in SG
dynamics (meaning formation, assembly, or disassembly)
contributes to poor cellular recovery to acute stress
[13-15]. We have previously shown that TDP-43 contri-
butes to cell survival 24 hr after stress exposure [12]. To
determine if this was a short- or long-term requirement
and whether this was exclusive to TDP-43, we extended
these studies such that cells transfected with specific
siRNAs for 48 hr were stressed (SA, 30 min) and then
assessed for cell viability at 24 and 48 hr by trypan blue
exclusion. In all cases, robust depletion of TDP-43,
G3BP, and FUS was achieved by the respective siRNAs
(Figure 5A, C). In the case of TDP-43 depleted HeLa
cells, we noted a 1.9-fold increase (p = 0.01) in cell death
in unstressed conditions at 48 hr while no significant
differences in viability were detected in siG3BP or siFUS
cells (Figure 5B). When challenged with SA treatment,
siTDP-43 cells fared worse than siControl cells 24 hr
later and cell death was further increased to 2.3-times
siControl cells at 48 hr (24 hr: p = 0.02; 48 hr: p = 0.01,
Figure 5B). Depletion of FUS had no impact on cell via-
bility at any time point, consistent with our data that
endogenous FUS is not required for a SG response. Sur-
prisingly, depletion of G3BP did not impact cellular re-
covery to oxidative stress in HeLa cells (Figure 5B).
However, additional experiments in the neuronal-like
cell line SK-N-SH revealed similarly increased cell vul-
nerability 48 hr post-SA treatment in both TDP-43 and
G3BP depleted cells (siTDP-43: 2.3-fold, p = 0.019;
siG3BP: 2.6-fold, p = 0.005) (Figure 5D). In contrast, as
in HeLa cells, FUS depletion had no effect on survival in
these neuronal-like cells. Thus, neuronal-like cells seem
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Figure 3 Blocked SG assembly in TDP-43 depleted cells is rescued by G3BP-GFP. (A - F) SG formation and resolution were assessed in HeLa
cells transfected with control or TDP- 43 siRNA for 48 hr, transfected with GFP or G3BP-GFP for 24 hr and subsequently treated with SA. Cover
slips were collected before SA treatment (A – C) and at 60 and 90 min after stress (D - F). (A) Western blot confirming expression of transfected
plasmids. Actin serves as a loading control. (B) Representative micrographs of quantified cells with spontaneous SG formation. Asterisks and
arrows indicate cells expressing G3BP-GFP with or without spontaneously forming SG, respectively. Scale bar, 20 μm. (C) Quantification of cells
with spontaneous SG formation (SG formation in the absence of stress). Cells were scored as SG positive when they had at least two TIA-1 foci of
a minimal size of 0.75 μm2. (D) Representative images quantified for SG number and size by semi-automatic analysis using ImageJ. Scale bar, 10
μm. (E & F) Number and size of SG were quantified at 60 and 90 min after SA treatment by semi-automatic analysis using ImageJ. The means of
3 independent experiments ± SEM are plotted. * p < 0.05.
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Figure 4 Endogenous FUS does not function in SG assembly in response to sodium arsenite. (A - E) SG were assessed in HeLa cells
transfected with control or FUS siRNA for 72 hr and subsequently treated with SA. (A & B) Quantification of individual SG size and number of SG
per cell. (C & D) Western blots and quantification of protein levels demonstrating that FUS does not regulate G3BP, TIA-1 or TDP-43, in HeLa cells
(left panel) nor in SK-N-SH cells (right panel). Actin serves as a loading control. The means of 3 independent experiments ± SEM are plotted. *
p < 0.05.
Aulas et al. Molecular Neurodegeneration 2012, 7:54 Page 7 of 14
http://www.molecularneurodegeneration.com/content/7/1/54
to be more vulnerable to a defect in SG assembly when
either TDP-43 or G3BP is depleted. In both lines, cells
transfected with control siRNA exhibited a background
level of cell death that was constant throughout the
experiments.
TIA-1 overexpression enhances cell toxicity of HeLa cells
TDP-43 depleted cells have not only a down-
regulation of G3BP but also a 30% up-regulation of
TIA-1 protein levels (and 2.6-fold increase in TIA-1
transcripts) [12] that is not observed in G3BP
depleted cells (Figure 2A). Since G3BP siRNA failed
to recapitulate the same level of toxicity as TDP-43
depletion in HeLa cells, we wondered if there was a
differential sensitivity to elevated TIA-1 expression
between cell types. To address this, we transiently
transfected cells with a low concentration of GFP-
tagged TIA-1 for 24 hr (Figure 6A, B). At 24 hr
post-transfection, we observed that cells with high
GFP-TIA-1 expression formed puncta resembling SG
in the absence of exogenous stress, in agreement with
a previous report [9]. (However, TIA-1 aggregates
were not detected at 48 hr, data not shown.) Cells
were then briefly stressed with SA (30 min) and the
media was replaced so as to permit cellular recovery
for 24 hr. In order to avoid inducing non-specific cell
death attributed to supraexpression of TIA-1, we used
a very low concentration of cDNA in these experi-
ments. This resulted in a low transfection efficiency.
Thus, in order to selectively assess cell death in GFP+
Figure 5 Neuronal-like cells have increased vulnerability to blocked SG assembly. (A & B) HeLa and (C & D) SK-N-SH cells treated with the
indicated siRNAs for 48 hr and then exposed to SA for 30 min. (A & C) Western blots confirming siRNA transfections in (A) HeLa and (D) SK-N-SH
cells. Actin serves as a loading control. (B & D) Cell death determined by trypan blue exclusion at the indicated times following SA treatment in
(B) HeLa and (D) SK-N-SH cells. The mean percentage of cell death is presented ± SEM of 3 independents experiments. * p < 0.05.
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transfectants (and thus exclude non-transfectants), we
employed a flow cytometry method to assess cell
death via Annexin V labelling specifically in GFP-
expressing cells. By this method, we observed that
GFP-TIA-1 transfected HeLa cells have a 2.3-fold
increased toxicity following SA treatment (p = 0.01,
Figure 6C). Also, we note that in unstressed/basal
conditions, GFP-TIA-1 transfected cells have nearly
twice the toxicity as control GFP transfected cells
(p = 0.005, Figure 6C). Note, while TIA-1 has been
previously described as cytotoxic, the toxicity
observed here is independent of the level of TIA-1
overexpression as demonstrated by independently
gating populations of high and low GFP-TIA-1 ex-
pression (Additional file 3: Figure S3). In contrast,
control GFP transfected cells were comparable to
untransfected cells in both basal and stressed condi-
tions. When we performed the same experiment in SK-N-
SH cells, we noted that TIA-1 over-expression did not
sensitize cells to SA (Figure 6C). Note, the apparent differ-
ence in TIA-1 expression detected by immunoblot likely
arises from a reduced transfection efficiency of SK-N-SH
cells (compare images in Figure 6A), while FACS analysis
was restricted to cells expressing either GFP or GFP-tagged
fusion protein. Taken together, these data suggest that low-
level overexpression of TIA-1 can be toxic to certain cell
Figure 6 HeLa cells have increased cell sensitivity to sodium arsenite in the presence of modestly elevated GFP-TIA-1 expression. (A–C)
HeLa (left panels) and SK-N-SH (right panels) cells were transfected with GFP or GFP-TIA-1 for 48 hr. (A) Representative images of HeLa (left
panels) and SK-N-SH (right panels) cells transfected with GFP or GFP-TIA-1 for 48 hr and then stained with TO-PRO3 to label nuclei. (B) Western
blot confirming TIA-1 expression. Asterisk (*) indicates non-specific bands from TIA-1 antibody. (C) Cell viability was assessed by Annexin V
labelling in HeLa and SK-N-SH. The means of 3 independent experiments ± SEM are plotted. * p<0.05.
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types and this toxicity can be exacerbated by the addition
of an exogenous stress.
Discussion
We previously reported that cells depleted of endogen-
ous TDP-43 formed smaller and less well-defined SG in
response to oxidative stress. In addition, we reported
that the reduction of endogenous TDP-43 levels induced
an up-regulation of TIA-1 and a down-regulation of
G3BP [12]. G3BP and TIA-1 are both considered to be
SG nucleating proteins based on studies where overex-
pression of either molecule is sufficient to induce SG
formation in the absence of stress [9,10]. While the re-
quirement for TIA-1 in SG initiation has been further
reinforced by the use of TIA-1 null cells [9], a similar
experiment has not been reported for G3BP. Using
siRNA-specific depletion of G3BP, we found that SG ini-
tiation defined by primary TIA-1 aggregation was undis-
turbed. We conclude that G3BP is not an essential SG
initiating factor. In contrast, SG assembly defined by the
secondary aggregation of TIA-1 resulting in fewer but
larger SG, was completely blocked by the reduction of
G3BP. This effect was nearly identical to that observed
in TDP-43 depleted cells. Moreover, the blockade in SG
assembly in TDP-43 depleted cells could be restored by
the addition of exogenous G3BP. Our data indicate that
TDP-43 regulation of G3BP controls SG assembly, an
important step in SG dynamics. Interestingly, a large-
scale analysis of TDP-43 target mRNAs has identified
TDP-43 as binding to G3BP mRNA at the 3’-UTR [41].
Our own experiments in HeLa cells using immunopreci-
pitation of TDP-43 followed by RT-PCR for G3BP tran-
scripts, confirm that TDP-43 can indeed bind G3BP
mRNA in at least one of the cell types used here (un-
published data). The exact mechanism(s) by which TDP-
43 regulates G3BP expression is the focus of future
investigations. Interestingly however, we note that our
data is strikingly similar to observations made in
poliovirus infection where G3BP is cleaved by the virus-
encoded 3C protease [42]. In this context, G3BP cleav-
age effectively inactivates G3BP, yielding smaller SG
compared to oxidative stress exposure [42,43]. It is
poignant to point out that poliovirus, which selectively
attacks motor neurons, can result in a post-infection
syndrome characterized by progressive muscle weakness
and paralysis in rare cases. Lastly, it is noteworthy that
G3BP-null mice are embryonically lethal, with animals
largely developing normally with the exception of wide-
spread neuronal cell death in various brain regions
(spinal cord was not examined) [44]. Collectively, these
data raise the possibility that SG dynamics (and the
G3BP axis) are an essential aspect to motor neuron sur-
vival. Future studies include validation of this hypothesis
in primary motor neurons.
Our previous work demonstrated that SG were mor-
phologically irregular and significantly smaller in cells
depleted of TDP-43 immediately following acute oxida-
tive stress [12]. We add here that these changes occur
while the number of SG per cell remains constant.
Collectively, these data suggest that TDP-43 can also
contribute to SG initiation. Whether the effect is direct
or indirect remains to be determined. As is the case for
G3BP and TIA-1, it is possible that TDP-43 controls the
expression of other SG residents essential to the process.
Further study of this aspect is required to identify a
TDP-43-regulated SG initiation factor(s) and/or deter-
mine if it is TDP-43 itself. While it is tempting to sug-
gest that it is G3BP which mediates this step, we note
that initial SG number and size is normal in G3BP
depleted cells. Clearly, endogenous TDP-43 contributes
to the regulation of SG dynamics at more than one level.
The function of SG is proposed to be the storage and
sorting of mRNA and SG are considered to be an im-
portant component of cell survival following stress ex-
posure [8]. Our experiments indicate that endogenous
TDP-43 is required to overcome acute oxidative stress
in both HeLa and the neuronal-like cell line SK-N-SH.
In contrast, endogenous FUS was not required in either
cell line. Taken together, we propose that TDP-43 tox-
icity in ALS favours a loss of protective function while
FUS mutations do not. In fact, given the number of
studies using cell models with overexpressed FUS
cDNAs, we propose that FUS mutations are gain-of-
function since overexpression seems to encourage SG
localization, with mutant FUS having a stronger
localization than wild type [26-28]. In addition, it has
been reported that mutant FUS is recruited to SG more
rapidly than wild type FUS suggesting that FUS muta-
tion causes a possible imbalance in normal SG dynamics
[27]. While this hypothesis may prove to be true, we find
it interesting that depletion of endogenous FUS had no
impact on SG initiation and assembly in the context of
acute oxidative stress.
Since TDP-43 and G3BP depletion yields the identical
effect on SG dynamics, we expected to observe the same
effect in our cell survival assay. To our surprise, our
hypothesis was true only in neuronal-like SK-N-SH cells.
That SG composition and/or kinetics are not identical in
different cell types has been previously reported [7,45].
Thus, while it is possible that HeLa cells have evolved
other means to avoid cell death in the absence of normal
SG kinetics, we feel that this data supports our hypoth-
esis that the proper control of SG dynamics is essential
to neuronal survival. Thus, the disruption of this mech-
anism could be an underlying element of motor neuron
vulnerability in ALS. However, given that the current
data is limited to transformed cell lines and acute oxida-
tive stress, future experiments in primary cultures
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exploring other ALS-relevant stress agents will be
required to fully evaluate this hypothesis.
TDP-43 depletion also leads to increased TIA-1 ex-
pression. While TIA-1 overexpression results in spon-
taneous SG formation, SG formation in the absence of
SA was never observed in TDP-43 depleted cells. Thus,
we wondered what may be the impact of moderately ele-
vated TIA-1 levels. TIA-1 is a strong translational re-
pressor [46] and is reported to induce apoptotic DNA
fragmentation in thymocytes [47]. In our hands, ectopic
TIA-1 expression induced spontaneous SG at 24 hr
post-transfection. However, these inclusions were no
longer observed at 48 hr, either due to cell death or
spontaneous resolution. Moreover, we also detected a
consistent 2-fold increase in cell death at 48 hr post-
transfection. Surprisingly, the expression of TIA-1 exa-
cerbated HeLa cell death 2.3-fold in response to an acute
exposure to SA. We speculate that the modest up-
regulation of TIA-1 induced by TDP-43 depletion
(which does not yield visible aggregates), leads to a pro-
tracted translational arrest that contributes to increased
cellular vulnerability. SK-N-SH cells were resistant to
exogenous TIA-1 expression. Motor neurons, the vul-
nerable cell type in ALS, have very particular mRNA
storage and protein translation mechanisms at the syn-
apse [48]. In the context of ALS, we speculate that the
reduction of functional TDP-43 levels (possibly via nu-
clear depletion) leads to a deregulation of normal SG
kinetics and altered molecular control of key compo-
nents relevant to cell survival. This contributes to a
prolonged translational arrest and increased cell vulner-
ability. While our data implies a functional significance
to the size/morphological changes associated with SG
assembly, future work is needed to more fully examine
the enigma that is “SG function” and the impact of
arrested translation. However, it is noteworthy that
increased SG size is widely viewed as a prerequisite to
proposed SG function in mRNA triage [8].
Mutations in both TDP-43 and FUS are causative for
ALS. In addition, both are RNA binding proteins that
localize to SG in response to thermal or oxidative stress
[12,23,25-28]. Many have expected that TDP-43 and
FUS would participate in the same cellular pathways and
that mutations in each would yield similar effects. How-
ever, we demonstrate here that the role for TDP-43 in
regulating SG dynamics appears to be specific since de-
pletion of endogenous FUS does not impact SG initi-
ation or assembly. Moreover, at the molecular level,
while TDP-43 and FUS have been reported to coopera-
tively regulate HDAC6 [39], we note here that reduction
of FUS levels does not impact G3BP or TIA-1 protein
levels in either of the cell types tested. In addition, in
our experiments FUS depletion does not impact TDP-43
levels, nor does TDP-43 appear to regulate FUS, in
contrast to a previous report [41]. This difference may
be due to cell type since this study assayed whole mouse
brain, while our study has examined cultured cell lines.
Conclusions
SG are a transient mechanism to manage cell stress. To
neurons, a non-renewable cell type, SG and other cellu-
lar stress response mechanisms are anticipated to be
extremely important to their long-term survival [31,49].
We demonstrate that endogenous TDP-43, via G3BP,
plays a role in SG dynamics that is independent of en-
dogenous FUS. This supports our view that TDP-43 and
FUS are not inter-changeable in all biological processes.
We also report that SG assembly plays a more
significant role in cell recovery following exposure to
exogenous stress in neuronal-like cells, compared to
non-neuronal cells. For future consideration, we
hypothesize that this inherent and subtle difference in
SG dynamics may be an underlying feature of the select-
ive cellular vulnerability in ALS (and possibly other neu-
rodegenerative diseases). Further studies using ALS
relevant cell types and disease-linked stressors are
warranted.
Methods
Cell culture and transfection
HeLa cells were grown in Dulbecco’s modified Eagle
medium (Invitrogen, Carlsbad, CA, USA), supplemented
with 10% fetal bovine serum and 1% glutamine. For trans-
fection of siRNA, 125 pmol of custom siRNAs were trans-
fected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA), according to the manufacturer’s instructions.
siRNA sequences used were: human FUS/TLS: 50-GGC





and #2 50- AAGAUGAGAACGAUGAGCCCAUUGA-30,
and negative control low GC siRNA (catalogue number
12935-200, Invitrogen, Carlsbad, CA, USA). Cells were
transfected at 30–50% confluency and collected after
72 hr. For transfection of cDNA, 0.3 μg GFP tagged
TIA-1 (provided by J. Goodier, Johns Hopkins University,
MD) or 0.3 μg of G3BP-GFP (provided by J. Tazi,
Montpellier, France) were transfected with Lipofectamine
LTX (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Cells were transfected with
cDNA 48 hr after siRNA treatment. Cells were collected
after 24 hr of treatment. Cells were treated with 0.5 mM
sodium arsenite (30 min, 37°C; Sigma). Recovery was
initiated by changing the media. Cells were fixed at the
indicated time points.
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Immunofluorescence and antibodies
Cells grown on cover slips were fixed in 1% formaldehyde
in phosphate buffered saline (PBS) and subsequently per-
meabilized with 0.1% Triton X-100 in PBS for 15 min.
Cover slips were blocked with 0.1% bovine serum albumin
(BSA) in PBS for 15 min and incubated with antibodies to
TDP-43 (1:400; Proteintech, Chicago, IL, USA), TIA-1
(1:100; Santa Cruz, Santa Cruz, CA, USA), G3BP (1:400;
BD Biosciences, Franklin Lakes, NJ, USA), diluted in block-
ing buffer for 1 hr at room temperature. Cover slips were
subsequently washed once with 0.1% Triton X-100 in PBS
and twice with 0.1% BSA in PBS. Labelling was visualized
with the fluorescently conjugated secondary antibodies
donkey anti-mouse Texas Red (1:200; Jackson Immuno-
chemicals, West Grove, PA, USA), donkey anti-rabbit
FITC (1:200; Jackson Immunochemicals, West Grove, PA,
USA), and donkey anti-goat Alexa 633 (1:800; Invitrogen,
Carlsbad, CA, USA). For some experiments, cells were
stained with TO-PRO 3 (1:300; Invitrogen, Carlsbad, CA,
USA) 10 min at room temperature. Cover slips were
washed tree times in PBS and mounted with ProLong
Antifade reagent (Invitrogen, Carlsbad, CA, USA). Images
were collected on a Leica SP5 confocal microscope.
Quantification of SG size and number
ImageJ was used for quantification of SG parameters. SGs
were identified by TIA-1 staining and cells were scored as
positive when they had at least two foci of a minimal size
of 0.75 μm2. Automatic recognition was done by Image J
using the following parameters, SGs ranging from 0.75 to
5 μm2, randomly selected in 10 cells per condition. The
average SG size of at least 100 SG is presented. For G3BP-
GFP experiments, cells with an average pixel intensity of
60 arbitrary fluorescent units were selected for analysis.
Control cells at this level of G3BP-GFP expression did not
exhibit SG formation in basal conditions.
Cell lysates and immunoblot analysis
Cells were collected in ice-cold PBS, lysed in RIPA buffer
(150 mM NaCl, 50 mM Tris pH 7.4, 1% Triton X-100,
0.1% SDS, 1% sodium deoxycholate, and protease inhibi-
tors), incubated 10 min on ice, 10 min at room
temperature, and centrifuged at 13 800 g. Supernatants
were collected and quantified with the BCA Protein Assay
Kit (Thermo Scientific, Waltham, MA, USA). The follow-
ing antibodies were used in immunoblotting: rabbit anti-
TDP-43 (1:5000; Proteintech, Chicago, IL, USA), goat
anti-TIA-1 (1:500; Santa Cruz Biotech, Santa Cruz, CA,
USA), mouse anti-G3BP (1:750; BD Biosciences, Franklin
Lakes, NJ, USA), rabbit anti-FUS (1:1000, Abcam,
Cambridge, MA, USA) and mouse anti-Actin (1:200 000;
MP Biomedicals, Santa Ana, CA, USA). Blots were visua-
lized with peroxidase-conjugated secondary antibodies
and ECL Western Blotting Substrate (Pierce, Waltham,
MA, USA). Densitometry was performed with Adobe
PhotoShop.
Protease sensitivity
Cells were collected in ice-cold PBS, lysed in 10 mM Tris
pH 8.0, 50 mM NaCl, 0.5 M sucrose, 0.1 mM EDTA, 0.5%
Triton X-100, 1 mM DTT. Cytoplasmic fractions were
recovered as supernatants after centrifugation at 230 g for
10 min and quantified with the BCA Protein Assay Kit
(Thermo Scientific, Waltham, MA, USA). 50 μg of cyto-
plasmic extract were incubated with increasing concentra-
tions of Proteinase K (0 - 1.6 mg/ml) for 5 min at 37°C.
Proteinase K was neutralised by 10 mM PMSF for 10 min
on ice [36]. Samples were then resuspended in 1X
Laemmli sample buffer.
Cell viability
Cell viability in siRNA depleted cells was scored via try-
pan blue exclusion at the indicated times after stress.
Cell viability/toxicity in GFP-TIA-1 transfected cells was
measured using the Annexin V/7-AAD labelling kit
(BD Biosciences, Franklin Lakes, NJ, USA) according to
the manufacturer’s instructions In these experiments,
cells were gated for GFP and Annexin V+ cells are
reported in the figure. Data acquisition was performed
on a BD LSR II flow cytometry (BD Biosciences) and
data was analyzed with FlowJo (Treestar, Ashland, OR).
Statistics
In all cases, data was compared via a two-tailed Student
t-test using Microsoft Excel.
Additional files
Additional file 1: Figure S1. Blocked stress granule assembly confirmed
with a second set of gene-specific siRNAs. HeLa cells were transfected
with independent siRNAs for the indicated genes. SG number and size
were quantified at the indicated times, as previously described in
Figures 1, 2, 3 and 4. The means of 3 independent experiments ± SEM
are plotted. * p < 0.05.
Additional file 2: Figure S2. Stress granule initiation is not affected by
G3BP and FUS. SG nucleation, as determined by TIA-1 labelling, was
assessed in HeLa cells transfected with control, G3BP or FUS siRNA for
72 hr and subsequently treated with SA (0.5 m M, 30 min) and then
immediately fixed. SG number and size were quantified using ImageJ.
The means of 3 independent experiments ± SEM are plotted. * p < 0.05.
Additional file 3: Figure S3. Toxicity is equivalent in high and low
expressing GFP-TIA-1 transfectants. (A–B) HeLa cells transfected with GFP
or GFP-TIA-1 for 48 hr (from Figure 6) were electronically gated for low
and high TIA-1 expression. Cell viability, as determined by Annexin V
labelling, was independently assessed in the two populations. The means
of 3 independent experiments ± SEM are plotted. * p < 0.05.
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Deacetylase 6; SA: Sodium Arsenite; SG: Stress Granule; SMA: Spinal Muscular
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